p38 MAPK signaling in osteoblast differentiation
E Rodríguez-Carballo, B Gámez… - Frontiers in cell and …, 2016 - frontiersin.org
The skeleton is a highly dynamic tissue whose structure relies on the balance between bone
deposition and resorption. This equilibrium, which depends on osteoblast and osteoclast …
deposition and resorption. This equilibrium, which depends on osteoblast and osteoclast …
Stem cell mechanobiology and the role of biomaterials in governing mechanotransduction and matrix production for tissue regeneration
SM Naqvi, LM McNamara - Frontiers in bioengineering and …, 2020 - frontiersin.org
Mechanobiology has underpinned many scientific advances in understanding how
biophysical and biomechanical cues regulate cell behavior by identifying mechanosensitive …
biophysical and biomechanical cues regulate cell behavior by identifying mechanosensitive …
[HTML][HTML] Irisin as an agent for protecting against osteoporosis: A review of the current mechanisms and pathways
Background Osteoporosis is recognized as a skeletal disorder characterized by diminished
bone tissue quality and density. Regular physical exercise is widely acknowledged to …
bone tissue quality and density. Regular physical exercise is widely acknowledged to …
[HTML][HTML] Focus on the p38 MAPK signaling pathway in bone development and maintenance
C Thouverey, J Caverzasio - BoneKEy reports, 2015 - ncbi.nlm.nih.gov
The p38 mitogen-activated protein kinase (MAPK) signaling pathway can be activated in
response to a wide range of extracellular signals. As a consequence, it can generate many …
response to a wide range of extracellular signals. As a consequence, it can generate many …
Mechanotransduction in tissue engineering: Insights into the interaction of stem cells with biomechanical cues
Stem cells in their natural microenvironment are exposed to biochemical and biophysical
cues emerging from the extracellular matrix (ECM) and neighboring cells. In particular …
cues emerging from the extracellular matrix (ECM) and neighboring cells. In particular …
Effect of polymeric matrix stiffness on osteogenic differentiation of mesenchymal stem/progenitor cells: concise review
Mesenchymal stem/progenitor cells (MSCs) have a multi-differentiation potential into
specialized cell types, with remarkable regenerative and therapeutic results. Several factors …
specialized cell types, with remarkable regenerative and therapeutic results. Several factors …
p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner
Bone mass is determined by the balance between bone formation, carried out by
mesenchymal stem cell-derived osteoblasts, and bone resorption, carried out by monocyte …
mesenchymal stem cell-derived osteoblasts, and bone resorption, carried out by monocyte …
Tmem161a regulates bone formation and bone strength through the P38 MAPK pathway
T Nagai, T Sekimoto, S Kurogi, T Ohta, S Miyazaki… - Scientific Reports, 2023 - nature.com
Bone remodeling is an extraordinarily complex process involving a variety of factors, such as
genetic, metabolic, and environmental components. Although genetic factors play a …
genetic, metabolic, and environmental components. Although genetic factors play a …
Orcinol glucoside targeted p38 as an agonist to promote osteogenesis and protect glucocorticoid-induced osteoporosis
W Zhao, LP Yao, P Sun, G Cheng, YL Liu, Y Yu, Y Liu… - Phytomedicine, 2023 - Elsevier
Background Glucocorticoids (GC)-induced osteoporosis (GIOP) is the most common cause
of secondary osteoporosis, which leads to an increased risk of fracture in patients. The …
of secondary osteoporosis, which leads to an increased risk of fracture in patients. The …
The SIRT1 activator SRT2104 promotes BMP9-induced osteogenic and angiogenic differentiation in mesenchymal stem cells
Y Lu, ZX Ma, R Deng, HT Jiang, L Chu… - Mechanisms of Ageing …, 2022 - Elsevier
Bone defects resulting from trauma, bone tumors, infections and skeletal abnormalities are a
common osteoporotic condition with respect to clinical treatment. Of the known bone …
common osteoporotic condition with respect to clinical treatment. Of the known bone …